About
Nessan Bermingham is an operating partner at Khosla Ventures with nearly three decades of experience in life sciences. He has founded and led multiple biotech companies focused on gene editing, RNA therapeutics, and cell therapies, including Intellia Therapeutics, which went public within two years of its founding. His investment experience spans public and private equities, debt instruments, and cross-border healthcare transactions.
Experience
- Khosla VenturesOperating Partnercurrent2021 — presentCambridge, MA
- Biotechnology Innovation OrganizationVice Chair BIO Investor Councilcurrent2026 — present
- D2B3Investor & Board Membercurrent2026 — presentNew Haven, CT
- Excelsior SciencesInvestor & Board Membercurrent2025 — presentNew York, NY
- Amide TechnologiesBoard Membercurrent2025 — presentWaltham, MA
- Kamau TherapeuticsInvestor & Board Membercurrent2024 — presentSouth San Francisco, CA
- Eligo BioscienceBoard Membercurrent2024 — presentParis
- Stylus MedicineInvestor & Board Membercurrent2024 — presentCambridge, MA
- Ochre BioBoard Membercurrent2022 — presentCambridge
- Liberate BioFounder, Investor & Board Membercurrent2022 — presentCambridge, MA
- EveryONE MedicinesFounder & Board Membercurrent2022 — presentBoston, MA
- Deep GenomicsBoard Membercurrent2022 — presentToronto Canada
- Korro Bio, Inc.Founder & Exec Chaircurrent2018 — presentCambridge, MA
- F-star Therapeutics, Inc.Chairperson2018 — 2023
- Triplet TherapeuticsFounder, CEO & Exec Chair2018 — 2022
- Atlas VentureVenture Partner2018 — 2020
- Xilio Therapeutics, Inc.Exec Chair2018 — 2020
- Intellia Therapeutics, Inc.Founder, President & CEO2014 — 2017
- Atlas VentureEIR2012 — 2014
- Omega FundsPartner2007 — 2008
- Atlas VentureAnalyst - Associate - Principle - Partner2002 — 2007
- UBSEquity Research Analyst2000 — 2001
Skills & more
Analytical SkillsBoard GovernanceBoard LevelFundraisingEntrepreneurshipLife SciencesPortfolio ManagementMolecular BiologyBusinessBiotechnologyFinancial AnalysisVenture Capital1
+9 more
Business FormationBiotechnology IndustryExec ChairIPOMergers & Acquisitions (M&A)FinancingsBusiness StrategyBusiness DevelopmentBusiness AnalysisFrom Nessan's professional profile.
Colleagues at Khosla Ventures
Adina Tecklu
Investor at Khosla Ventures
Adrian Radu
Investor at Khosla Ventures
Alex Morgan
Investor at Khosla Ventures
Alice Brooks
Investor at Khosla Ventures
Amy Kalokerinos
Investor at Khosla Ventures
Anne Foor
Investor at Khosla Ventures
Austin Hay
Investor at Khosla Ventures
Avisha Mehra Naganath
Investor at Khosla Ventures
Frequently asked questions
- Who is Nessan Bermingham?
- Nessan Bermingham is an operating partner at Khosla Ventures with nearly three decades of experience in life sciences. He has founded and led multiple biotech companies focused on gene editing, RNA therapeutics, and cell therapies, including Intellia Therapeutics, which went public within two years of its founding. His investment experience spans public and private equities, debt instruments, and cross-border healthcare transactions.
- Where does Nessan Bermingham work?
- Nessan Bermingham is Operator at Khosla Ventures.
- Where did Nessan Bermingham go to school?
- Nessan Bermingham studied at Baylor College of Medicine (Post doctoral research - Howard Hughes Assoc Fellow); Imperial College London (Doctor of Philosophy - PhD, Molecular Biology); Queen's University Belfast (Bachelor's degree, Genetics).
Founder mafias
Imperial College London mafia196
Also came through, then founded or led a company.
Brent HobermanAdvisor, Innovation FundFounded Founders Pledge +3Alice BentinckComputer Science Department Industrial Liaison BoardFounded Entrepreneurs First +1Ahmed DeyabMSc Advanced Computational Methods for AeronauticsFounded Instagram +1Sebastian TrousilPhDFounded City Therapeutics +1Slava SolonitsynMBAFounded No Cap +1Barnaby MaletTeaching AssistantFounded machine0 +1
+ 189 more
UCL mafia117
Also came through, then founded or led a company.
Demis HassabisPhDFounded Google Deepmind +2Gustavo GorensteinMaster of Science (M.Sc.)Founded bxblue +1Radu MaziluBachelor of Science (BSc)Founded PermitPortal +1Nodar DaneliyaFounded Shuttle +1Nicolas HourcardCorporate FinanceFounded QuestDB +1Mark TrefgarneBAFounded Liverail +1
+ 110 more
UBS mafia33
Also came through, then founded or led a company.
Vlad IlyushchenkoCash Equities Order Management DeveloperFounded QuestDB +1Rosi BodnarSenior Executive AssistantFounded EvozyneChris BaeManaging DirectorFounded Enhanced Digital GroupCorrey VooGroup CTOFounded 01 VenturesSven KarlssonSummer Internship ProgramFounded PrevivoredgeLukasz MusialskiInternFounded Deutsche Digital Assets
+ 26 more
Khosla Ventures mafia14
Also came through, then founded or led a company.
Vinod KhoslaFounderFounded AliveCorDelian AsparouhovPrincipalFounded Nightingale +1Uri LopatinOperatorFounded Pardes Biosciences +1Hari ArulInvestorFounded BoldAustin HayOperatorFounded ClarifyJustin KaoPartnerFounded Helix
+ 7 more
Atlas Venture mafia13
Also came through, then founded or led a company.
Romesh SubramanianEntrepreneur In ResidenceFounded RaNA Therapeutics +2Phillip SamayoaVenture PartnerFounded Generation Bio +2Jason RhodesPartnerFounded Rectifypharma +1Sumit AgarwalAssociateFounded Shape Security +1Kevin BittermanPartnerFounded Editas MedicineJohn MaraganoreVenture PartnerFounded Alnylam
+ 6 more
Same school
Also attended Baylor College of Medicine19
Lucy LiuPrincipal at Longwood FundJonathan MercadoPrincipal at First Bight VenturesCollin McCollAnalyst at First Bight VenturesPhil SangerManaging Partner at TEXO VenturesDavid SidranskyCo-Founder and Managing Partner at Israel Biotech FundFarzad SoleimaniPartner at 1984 Ventures Management, Llc
+ 13 more
Also attended Imperial College London499
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniPauline BoucherInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at Medicxi
+ 493 more
Also attended Queen's University Belfast31
Johnathan GrahamHead of Compliance at Fuel VenturesNicole StumpExecutive Assistant at Ensemble VCAndrew DryliePrincipal at Quadri VenturesJim CurranInvestment Director at Clarendon Fund Managers Ltd.Damien CallaghanChairman at Clarendon Fund Managers Ltd.Stuart GaffikinSenior Investment Manager at Clarendon Fund Managers Ltd.
+ 25 more
.jpeg)
